Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Also, in addition to yesterday's NR on the proteomic data from the Phase 1 CKD trial, there was a news release from November 17, 2016 on the favorable RVX-208 pharmacokinetic data in that trial.
